Cortical stimulation induces Fos expression in striatal neurons via NMDA glutamate and dopamine receptors
暂无分享,去创建一个
M. J. Guerra | I. Liste | J. Labandeira-Garcia | J. L. Labandeira-Garcia | G. Rozas | M. Guerra | I. Liste | G. Rozas | J. Labandeira-García
[1] H. Fibiger,et al. D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons , 1992, Neuroscience.
[2] G. Hanson,et al. Role of N-methyl-d-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems , 1992, Brain Research.
[3] J. Mcnamara,et al. NMDA and non-NMDA receptor-mediated increase of c-fos mRNA in dentate gyrus neurons involves calcium influx via different routes , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[4] U. Ungerstedt,et al. Dopamine D1 and D2 receptor antagonism differentially modulates stimulation of striatal neurotransmitter levels by N-methyl-D-aspartic acid. , 1994, European journal of pharmacology.
[5] A. Parent,et al. Synaptic relationships between dopaminergic afferents and cortical or thalamic input in the sensorimotor territory of the striatum in monkey , 1994, The Journal of comparative neurology.
[6] H. Tilson,et al. Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage , 1988, Brain Research.
[7] J. Glowinski,et al. Release of dopamine evoked by electrical stimulation of the motor and visual areas of the cerebral cortex in both caudate nuclei and in the substantia nigra in the cat , 1978, Brain Research.
[8] L. Fowler,et al. N-methyl-d-aspartate receptors modulate extracellular dopamine concentration and metabolism in rat hippocampus and striatum in vivo , 1994, Brain Research.
[9] F. Sharp,et al. N-methyl-d-aspartate receptor activation in the neostriatum increases c-fos and fos-related antigens selectively in medium-sized neurons , 1991, Neuroscience.
[10] G. Vincendon,et al. Dopamine D2 receptor antagonists induce immediate early genes in the rat striatum , 1992, Brain Research Bulletin.
[11] A. Graybiel,et al. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[12] J. Joyce,et al. Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, Alzheimer's disease, and mixed Parkinson's disease/Alzheimer's disease patients: an autoradiographic study , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[13] J. Penney,et al. Glutamate receptor expression in rat striatum: Effect of deafferentation , 1994, Brain Research.
[14] J. Joyce,et al. Dopamine D-2 receptors in rat caudate-putamen: the lateral to medial gradient does not correspond to dopaminergic innervation , 1985, Brain Research.
[15] R. Rimondini,et al. The modulation of dopaminergic transmission in the striatum by MK-801 is independent of presynaptic mechanisms , 1992, Neuropharmacology.
[16] U. Ungerstedt,et al. Bilateral regulation of glutamate tissue and extracellular levels in caudate-putamen by midbrain dopamine neurons , 1990, Neuroscience Letters.
[17] A. Lajtha,et al. NMDA receptors are not involved in the MK-801-induced increase of striatal dopamine release in rat: a microdialysis study , 1994, Brain Research.
[18] J. Penney,et al. Glutamate receptors in striatum and substantia nigra: Effects of medial forebrain bundle lesions , 1994, Brain Research.
[19] P. Roberts,et al. STIMULATORY EFFECT OF l‐GLUTAMATE AND RELATED AMINO ACIDS ON [3H]DOPAMINE RELEASE FROM RAT STRIATUM: AN IN VITRO MODEL FOR GLUTAMATE ACTIONS , 1979, Journal of neurochemistry.
[20] F. Fonnum,et al. Glutamate in cortical fibers. , 1981, Advances in biochemical psychopharmacology.
[21] G. Chiara,et al. l-Dopa stimulates c-fos expression in dopamine denervated striatum by combined activation of D-1 and D-2 receptors , 1993, Brain Research.
[22] B. Bloch,et al. Fos Immunoreactivity after Stimulation or Inhibition of Muscarinic Receptors Indicates Anatomical Specificity for Cholinergic Control of Striatal Efferent Neurons and Cortical Neurons in the Rat , 1993, The European journal of neuroscience.
[23] M. Dragunow,et al. D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons , 1990, Neuroscience.
[24] J. Marshall,et al. Elevated NMDA receptors in parkinsonian striatum. , 1992, Neuroreport.
[25] J. Penney,et al. The functional anatomy of basal ganglia disorders , 1989, Trends in Neurosciences.
[26] B. Scatton,et al. N-methyl-D-aspartate-type receptors mediate striatal 3H-acetylcholine release evoked by excitatory amino acids , 1982, Nature.
[27] M. Zigmond,et al. High glutamate concentrations evoke Ca(++)-independent dopamine release from striatal slices: a possible role of reverse dopamine transport. , 1991, The Journal of pharmacology and experimental therapeutics.
[28] A. D. Smith,et al. The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones , 1990, Trends in Neurosciences.
[29] H. Fibiger,et al. Cortical regulation of acetylcholine release in rat striatum , 1994, Brain Research.
[30] M. Cuénod,et al. Glutamate release in vitro from corticostriatal terminals , 1979, Brain Research.
[31] A. Grace,et al. Compensatory responses to nigrostriatal bundle injury. Studies with 6-hydroxydopamine in an animal model of parkinsonism. , 1989, Molecular and chemical neuropathology.
[32] Toshifumi Yamamoto,et al. Differential effects of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism in freely moving rats , 1989, Brain Research.
[33] A. Graybiel,et al. Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum. , 1992, Journal of neurophysiology.
[34] A. Nieoullon,et al. N-methyl-d-aspartate receptor blockade impairs behavioural performance of rats in a reaction time task: New evidence for glutamatergic-dopaminergic interactions in the striatum , 1994, Neuroscience.
[35] A. Nieoullon,et al. Localization of N‐Methyl‐d‐Aspartate Receptors in the Rat Striatum: Effects of Specific Lesions on the [3H]3‐(2‐Carboxypiperazin‐4‐yl)propyl‐1‐Phosphonic Acid Binding , 1990, Journal of neurochemistry.
[36] A. Björklund,et al. Prefrontal Corticostriatal Afferents Maintain Increased Enkephalin Gene Expression in the Dopamine‐denervated Rat Striatum , 1994, The European journal of neuroscience.
[37] A. Carlsson,et al. Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease , 1990, Trends in Neurosciences.
[38] S. Hernández,et al. NMDA receptor mediates dopamine release in the striatum of unanesthetized rats as measured by brain microdialysis , 1992, Brain Research.
[39] A. Snyder-Keller. Striatal C-fos induction by drugs and stress in neonatally dopamine-depleted rats given nigral transplants: Importance of NMDA activation and relevance to sensitization phenomena , 1991, Experimental Neurology.
[40] M. Kelland,et al. Behavioral and electrophysiological comparison of ketamine with dizocilpine in the rat , 1993, Physiology & Behavior.
[41] L. Fowler,et al. Regional effects of MK-801 on dopamine and its metabolites studied by in vivo microdialysis , 1992, Neuroscience Letters.
[42] A. Graybiel,et al. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[43] Micaela Morelli,et al. Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions , 1994, Trends in Neurosciences.
[44] S. Deutsch,et al. A "glutamatergic hypothesis" of schizophrenia. Rationale for pharmacotherapy with glycine. , 1989, Clinical neuropharmacology.
[45] F. Vaccarino,et al. Differential induction of immediate early genes by excitatory amino acid receptor types in primary cultures of cortical and striatal neurons. , 1992, Brain research. Molecular brain research.
[46] G. Di Chiara,et al. Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression. , 1992, The Journal of pharmacology and experimental therapeutics.
[47] J. Labandeira-Garcia,et al. Cortical stimulation induces fos expression in intrastriatal striatal grafts , 1994, Brain Research.
[48] E. Scarnati,et al. Influence of prelimbic and sensorimotor cortices on striatal neurons in the rat: electrophysiological evidence for converging inputs and the effects of 6-OHDA-induced degeneration of the substantia nigra , 1993, Brain Research.
[49] G. Chiara,et al. Glutamate as a neurotransmitter , 1981 .
[50] A. Imperato,et al. NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus. , 1990, European journal of pharmacology.
[51] R. M. Beckstead,et al. Cortical stimulation induces Fos expression in striatal neurons , 1992, Neuroscience.
[52] A. Grace. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia , 1991, Neuroscience.
[53] A. Mcgeorge,et al. The organization of the projection from the cerebral cortex to the striatum in the rat , 1989, Neuroscience.
[54] W. Low,et al. Glutamate Uptake Blockade Induces Striatal Dopamine Release in 6-Hydroxydopamine Rats with Intrastriatal Grafts: Evidence for Host Modulation of Transplanted Dopamine Neurons , 1994, Experimental Neurology.
[55] J. Labandeira-Garcia,et al. Comparison between normal developing striatum and developing striatal grafts using drug-induced fos expression and neuron-specific enolase immunohistochemistry , 1994, Neuroscience.
[56] A. Björklund,et al. Transection of Corticostriatal Afferents Reduces Amphetamine‐ and Apomorphine‐induced Striatal Fos Expression and Turning Behaviour in Unilaterally 6‐Hydroxydopamine‐lesioned Rats , 1993, The European journal of neuroscience.
[57] S. Young,et al. Terminal excitability of the corticostriatal pathway. II. Regulation by glutamate receptor stimulation , 1991, Brain Research.
[58] A. Björklund,et al. Intrinsic Organization and Connectivity of Intrastriatal Striatal Transplants in Rats as Revealed by DARPP‐32 Immunohistochemistry: Specificity of Connections with the Lesioned Host Brain , 1989, The European journal of neuroscience.
[59] J. Desce,et al. l-Glutamate-evoked release of dopamine from synaptosomes of the rat striatum: Involvement of AMPA and N-methyl-d-aspartate receptors , 1992, Neuroscience.
[60] C. Rivier,et al. Cocaine-induced expression of striatal c-fos in the rat is inhibited by NMDA receptor antagonists , 1993, Brain Research Bulletin.
[61] J. Warter,et al. Behavioural, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat , 1991, Neuroscience Letters.
[62] Takao Shimizu,et al. Ketamine-induced anesthesia involves the N-methyl-d-aspartate receptor-channel complex in mice , 1992, Brain Research.
[63] C. Wilson,et al. Anatomical and physiological properties of the cortical and thalamic innervations of neostriatal tissue grafts. , 1990, Progress in brain research.
[64] G. Reynolds,et al. Glutamate stimulates dopamine release from cortical and limbic rat brain in vitro. , 1993, European journal of pharmacology.
[65] H. Fibiger,et al. Dopaminergic regulation of striatal acetylcholine release: importance of D1 and N-methyl-D-aspartate receptors. , 1991, The Journal of pharmacology and experimental therapeutics.
[66] J. Penney,et al. Organization of N‐methyl‐D‐aspartate glutamate receptor gene expression in the basal ganglia of the rat , 1994, The Journal of comparative neurology.
[67] A. Jayaraman,et al. Nicotine induced c-fos expression in the striatum is mediated mostly by dopamine D1 receptor and is dependent on NMDA stimulation. , 1994, Brain research. Molecular brain research.
[68] C. Wilson,et al. Restoration of the corticostriatal projection in rat neostriatal grafts: electron microscopic analysis , 1989, Neuroscience.
[69] H. Fibiger,et al. Electrical Stimulation of the Medial Prefrontal Cortex Increases Dopamine Release in the Striatum , 1993, Neuropsychopharmacology.
[70] Greg A. Gerhardt,et al. Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats , 1993, Brain Research.
[71] R. Roth,et al. Effect ofl-glutamate on the release of striatal dopamine: in vivo dialysis and electrochemical studies , 1990, Brain Research.
[72] A. Gobert,et al. The glutamate-mediated release of dopamine in the rat striatum: Further characterization of the dual excitatory-inhibitory function , 1990, Neuroscience.
[73] S. Young,et al. Terminal excitability of the corticostrial pathway. I. Regulation by dopamine receptor stimulation , 1991, Brain Research.
[74] A. Nieoullon,et al. Functional interactions between glutamate and dopamine in the rat striatum , 1994, Neurochemistry International.
[75] A. Björklund,et al. Development of intrastriatal striatal grafts and their afferent innervation from the host , 1991, Neuroscience.
[76] T. Curran,et al. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. , 1991, Annual review of neuroscience.